Related Experiment Videos
Recurrent hemolytic uremic syndrome and metastatic malignancy
American Journal of Nephrology
|January 1, 1987
Summary
Malignancy-associated hemolytic-uremic syndrome (HUS) can occur in adults with prostate cancer. Early suspicion and diagnosis of cancer-associated HUS may lead to a better prognosis, even with advanced disease.
Area of Science:
- Nephrology
- Oncology
- Hematology
Background:
- Malignancy is an uncommon cause of hemolytic-uremic syndrome (HUS) in adults.
- Prostatic adenocarcinoma is a potential underlying condition associated with HUS.
Observation:
- A 64-year-old male with prostatic adenocarcinoma experienced two episodes of HUS without renal sequelae.
- The temporal association with cancer progression and lack of chemotherapy supported a diagnosis of cancer-associated HUS.
Findings:
- This case and literature review suggest malignancy should be suspected in adult HUS patients.
- Cancer-associated HUS prognosis may not be poor despite progressive malignancy.
Implications:
- Highlights the importance of considering malignancy in adult HUS differential diagnosis.
- Suggests a potentially manageable prognosis for cancer-associated HUS, warranting further investigation.